Home > > Asia And Global Clinical Laboratory Services Market- Size, Share, Growth Rate, and Forecast
The Asia Clinical Laboratory Services market was valued at $389.3 Million in 2023, and is projected to reach $918.1 Million by 2030 growing at a CAGR of 13.09% from 2024 to 2030. Ancestry & Relationship Testing segment is expected to be the highest contributor to this market, with $159.0 Million in 2023, and is anticipated to reach $376.1 by 2030, registering a CAGR of 13.15%. Nutrigenomic Testing segment is anticipated to reach $177.7 Million by 2030 with the highest CAGR of 13.27%. Ancestry & Relationship Testing and Nutrigenomic Testing segments collectively expected to account for about 60.0% share of the Asia Clinical Laboratory Services market in 2023, with the former constituting around 40.8% share. Nutrigenomic Testing and Carrier testing segments are expected to witness significant growth rates at a CAGR of 13.27% and 13.18% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 33.1% in the overall Asia Clinical Laboratory Services market in 2023, and is anticipated to reach 33.4% by 2030. Test type Carrier testing Predictive testing Ancestry & Relationship Testing Nutrigenomic Testing Other Test Types Distribution Channel Online platforms Over-the-counter Technology Targeted analysis Single nucleotide polymorphism (SNP) chips Whole genome sequencing (WGS) BY REGION North America U.s. Canada Mexico Europe Germany France UK Italy Spain Russia Rest of Europe Asia China India Japan Australia Rest of Asia Middle East Africa Brazil South Africa GCC Rest of Middle East Africa